Summarized by Masters of Longevity from Longevity Technology.
AI-driven 'virtual cell' modeling gets explained in a methods-focused article that outlines a new benchmarking approach for genetic perturbation models. Read on to learn how the paper evaluates and recalibrates model scoring so researchers can more confidently apply virtual-cell screens to aging-related target discovery.
Key Takeaways
- Shift Bioscience and Nature Biotechnology describe an improved calibration framework for genetic perturbation models that predicts gene effects.
- Shift plans to apply the framework to combined in vitro and in silico screens to find dual-purpose inhibition targets for rejuvenation and disease.
- Shift is focusing initial applications on fibrosis and cites SB-101 as a previously identified dual-purpose target in its pipeline.
